OPJENSTO Trademark

Prosecution Summary

Trademark Summary
OPJENSTO is a standard character word mark covering pharmaceutical preparations for the treatment and prevention of various diseases and disorders including bone, cardiovascular, oncological, and autoimmune conditions, along with antibiotics, antivirals, and human vaccines in class 005, plus goods/services in classes 006, 018, 044, 046, 051, and 052. The mark is owned by Merck Sharp & Dohme B.V., a Dutch B.V. based in Haarlem, Netherlands. It is currently registered on the Principal Register, with registration number 8137191 issued on February 10, 2026.

Recent Activity
Filed on July 15, 2025, with priority claimed from a Benelux registration (no. 1528959), the application faced a suspension inquiry in September 2025, followed by a response

Trademark Facts

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Related

• All trademarks from Merck Sharp & Dohme B.V.
• More marks in Class 005
• Search for similar marks to OPJENSTO
• Run a clearance check
• Free USPTO trademark search